Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC).
暂无分享,去创建一个
E. Van Cutsem | F. Lordick | A. Sawaki | M. Lehle | H. Chung | A. Feyereislova | Y. Kang | Y. Bang | J. Hill